
FDA Grants Fast Track Designation to Amlenetug for Possible Treatment of Multiple System Atrophy
The FDA granted fast track designation (FTD) to amlenetug, an investigational human monoclonal antibody from Lundbeck, for further examination as a potential novel therapy for patients with multiple system atrophy (MSA), according to a news release from …